Rivaroxaban in treatment refractory heparin-induced thrombocytopenia.

BMJ Case Rep 2016 Aug 12;2016. Epub 2016 Aug 12.

Department of Haematology, Monash Health, Clayton, Victoria, Australia.

Following orthopaedic surgery, a 56-year-old woman developed heparin-induced thrombocytopenia (HIT), complicated by extensive proximal deep vein thrombosis. The patient did not respond to multiple conventional therapies; however, a prompt treatment response occurred after starting rivaroxaban at standard dosing. This case represents the first documentation of efficacy for rivaroxaban in the setting of treatment refractory HIT and strengthens the limited existing evidence for this agent in HIT.

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2016-216110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986039PMC
August 2016
3 Reads

Publication Analysis

Top Keywords

treatment refractory
8
heparin-induced thrombocytopenia
8
response occurred
4
treatment response
4
occurred starting
4
starting rivaroxaban
4
standard dosing
4
rivaroxaban standard
4
prompt treatment
4
therapies prompt
4
patient respond
4
vein thrombosis
4
respond multiple
4
conventional therapies
4
dosing case
4
thrombosis patient
4
represents documentation
4
limited existing
4
strengthens limited
4
existing evidence
4

Similar Publications